Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
58
NMPA:58
Drug Approvals
Aspirin Enteric-coated Tablets
- Product Name
- 阿司匹林肠溶片
- Approval Number
- 国药准字H20253885
- Approval Date
- Apr 15, 2025
NMPA
Sacubitril Valsartan Sodium Tablets
- Product Name
- 沙库巴曲缬沙坦钠片
- Approval Number
- 国药准字H20258061
- Approval Date
- Apr 9, 2025
NMPA
Dabigatran Etexilate Capsules
- Product Name
- 达比加群酯胶囊
- Approval Number
- 国药准字H20244408
- Approval Date
- Oct 15, 2024
NMPA
Dabigatran Etexilate Capsules
- Product Name
- 达比加群酯胶囊
- Approval Number
- 国药准字H20244407
- Approval Date
- Oct 15, 2024
NMPA
Sacubitril Valsartan Sodium Tablets
- Product Name
- 沙库巴曲缬沙坦钠片
- Approval Number
- 国药准字H20234678
- Approval Date
- Dec 26, 2023
NMPA
Clindamycin Phosphate Injection
- Product Name
- 克林霉素磷酸酯注射液
- Approval Number
- 国药准字H20234474
- Approval Date
- Nov 14, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found